Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it

Page 2 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.

• GLP-1 RA for Stage 1 Type 1 DiabetesNot yet recruitingNCT07430332Phase 2
• Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide ImplantNot yet recruitingNCT07430059Phase 1
• Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With DiabetesRecruitingNCT07428746Phase 3
• Tirzepatide (Spartina) in Obese Kidney Transplant RecipientsRecruitingNCT07423247Phase 4
• Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in PsoriasisRecruitingNCT07401992Phase 4
• Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.Not yet recruitingNCT07391267Not applicable
• Semaglutide PrIor to CathEeter Ablation in Patients With Atrial FibrillationNot yet recruitingNCT07389941Phase 4
• Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes MellitusRecruitingNCT07374328Phase 1/2
• Tirzepatide and Muscle Outcomes in ObesityRecruitingNCT07373834Not applicable
• A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young AdultsRecruitingNCT07364175Not applicable
• IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol SecretionRecruitingNCT07361874Not applicable
• A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial CancerNot yet recruitingNCT07349641Phase 2
• Effect of Semaglutide and Tirzepatide Combined With Exercise in ObesityNot yet recruitingNCT07319975Not applicable
• Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes MellitusEnrolling by invitationNCT07319286Phase 1/2
• Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 DiabetesRecruitingNCT07317115Not applicable
• GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DMRecruitingNCT07314684Phase 4
• Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With ObesityRecruitingNCT07293325Not applicable
• Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)Not yet recruitingNCT07292519Phase 2
• A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood SugarRecruitingNCT07284511Phase 2/3
• Semaglutide (Wegovy) Treatment for TrichotillomaniaNot yet recruitingNCT07282769Phase 2
• Role of GLP1 RA Dulaglutide on Severe Intracranial AtherosclerosisRecruitingNCT07282041Phase 2/3
• Waiting on Atrial Fibrillation Intervention Therapy (WAIT) StudyRecruitingNCT07275697Phase 4
• The Impact of Semaglutide Compared to Energy Restriction on Type 2 DiabetesRecruitingNCT07272343Phase 4
• Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07265752Phase 2
• Tirzepatide's Role in Postmenopausal HR+ Breast Cancer SurvivorsRecruitingNCT07257484Phase 4
• Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetesRecruitingNCT07254572Phase 4
• A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightRecruitingNCT07253285Phase 3
• GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic ArthritisNot yet recruitingNCT07251556Phase 4
• A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)RecruitingNCT07247084Phase 4
• Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and ObesityRecruitingNCT07245771Phase 1/2
• Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlRecruitingNCT07244003Phase 4
• Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.RecruitingNCT07242534Phase 4
• A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)RecruitingNCT07241390Phase 3
• A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney DiseaseRecruitingNCT07239570Phase 4
• Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With ObesityRecruitingNCT07228741Phase 2
• Repurposing Semaglutide for the Treatment of Cocaine Use DisorderRecruitingNCT07227948Phase 2
• Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)RecruitingNCT07225816Phase 1
• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery DiseaseRecruitingNCT07223593Phase 3
• GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIVRecruitingNCT07221214Phase 2
• Tirzepatide to Slow Biological AgingRecruitingNCT07220473Phase 2
• The Effect of Tirzepatide on Menopausal Vasomotor Symptoms and Biological Aging in Post-menopausal Women With ObesityRecruitingNCT07218445Phase 4
• Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)RecruitingNCT07218354Phase 3
• Individualized Pharmacological Approach to Obesity in Patients With Bipolar DisorderRecruitingNCT07213466Phase 4
• Albuminuria Reduction Study With Survodutide Treatment in Kidney DiseaseNot yet recruitingNCT07206290Phase 2
• Glutide for Ending MethamphetamineRecruitingNCT07204249Phase 2
• A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or OverweightRecruitingNCT07202884Phase 3
• Oral Semaglutide in Patients With Alzheimer's DiseaseNot yet recruitingNCT07200622Phase 2
• Tirzepatide in Idiopathic Intracranial Hypertension TrialRecruitingNCT07191873Phase 4
• Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm HealthNot yet recruitingNCT07179120Phase 2
• Efficacy and Safety of Tirzepatide (Spartina) in Chronic Kidney FailureNot yet recruitingNCT07176663Not applicable
• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)RecruitingNCT07165028Phase 3
• GLP-1R Actions on Muscle and the SkeletonRecruitingNCT07154719Phase 4
• Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or ObesityRecruitingNCT07136714Phase 4
• Improved Treatment and Monitoring of Alzheimer's DiseaseNot yet recruitingNCT07135245Phase 2
• Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled TrialRecruitingNCT07111494Phase 4
• A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)RecruitingNCT07101939Phase 2
• Tirzepatide Use in People With Obesity and Type 1 DiabetesRecruitingNCT07096908Phase 4
• Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal TumorsRecruitingNCT07095517Phase 1
• Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024RecruitingNCT07091734Phase 2
• Semaglutide in Patients Undergoing Transcatether Aortic Valve ReplacementNot yet recruitingNCT07090343Phase 3
• Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial CancerNot yet recruitingNCT07078838Phase 2
• The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential MechanismsNot yet recruitingNCT07073053Phase 4
• Tirzepatide in Obesity-Driven Endometrial CancerRecruitingNCT07065552Early Phase 1
• Semaglutide for Smoking Cessation in Patients With DiabetesRecruitingNCT07059377Phase 3
• Tirzepatide in MetALDRecruitingNCT07046819Phase 2
• Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 SemaglutideRecruitingNCT07040592Phase 2
• Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled TrialNot yet recruitingNCT07030621Phase 3
• Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)RecruitingNCT07029009Phase 2
• Brain Plasticity and GLP-1 Receptor Agonist Treatment for ObesityNot yet recruitingNCT07021937Phase 3
• Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity LymphedemaRecruitingNCT07012642Early Phase 1
• The Role of the Amylin Analogue Cagrilintide in Bone MetabolismRecruitingNCT07010432Phase 1
• Tirzepatide for Alcohol Use DisorderRecruitingNCT06994338Phase 2
• Protein Supplementation Intervention on Body WeightRecruitingNCT06989203Not applicable
• Impact of Semaglutide on Tobacco Use and Related Health BehaviorsRecruitingNCT06986993Phase 4
• GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way ForwardNot yet recruitingNCT06977438Phase 4
• Moving Beyond Inflammation as a Therapeutic Target for Crohn's DiseaseRecruitingNCT06976853Phase 2
• The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesRecruitingNCT06976619Phase 2
• Assessing Incretin Therapy for Cardiovascular Risk Reduction and Diabetes Remission( ITCRDR Study)Enrolling by invitationNCT06959784Phase 4
• Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility StudyEnrolling by invitationNCT06954090Phase 4
• Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use DisorderRecruitingNCT06939088Phase 2
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightRecruitingNCT06937099Phase 3
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRecruitingNCT06937086Phase 3
• Effect of Semaglutide in Patients With Psoriasis and ObesityRecruitingNCT06937060Phase 3
• Early Reinitiation of Semaglutide Post-Sleeve Gastrectomy in YouthRecruitingNCT06934655Phase 3
• Effect of Tirzepatide on Markers of MASLD in Patients With ObesityRecruitingNCT06934642Early Phase 1
• Semaglutide for the Prevention Of Post-Transplant Diabetes MellitusNot yet recruitingNCT06913023Phase 2/3
• Semaglutide Treatment in Type 1 DiabetesNot yet recruitingNCT06909006Phase 3
• Tirzepatide in PWS, HO and GNSORecruitingNCT06901245Phase 4
• A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 DiabetesRecruitingNCT06894784Phase 3
• PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese AdultsNot yet recruitingNCT06863363Phase 4
• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)RecruitingNCT06857942Phase 4
• JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With ObesityRecruitingNCT06852391Phase 4
• Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating DisorderRecruitingNCT06847399Phase 2
• Semaglutide's Weight Loss Effects in ObesityNot yet recruitingNCT06825793Not applicable
• Acute Metabolic Effects of Tirzepatide in Type 1 DiabetesRecruitingNCT06820281Phase 2
• Effects of Tirzepatide on Muscle and Vascular Health in Obese Older AdultsRecruitingNCT06811324Phase 2
• TIRzepatide for the Treatment of Obesity in Patients With Atrial FibrillationRecruitingNCT06802081Phase 2
• A Study Investigating Oral Semaglutide in People with Open-Angle GlaucomaRecruitingNCT06792422Phase 4
• Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular TreatmentNot yet recruitingNCT06788626Phase 3
• Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) PatientsRecruitingNCT06774079Phase 4

← Glucagon-Like Peptide-1 Receptor Agonists overview